ADA and ADK, identified as key target genes of ADORA2A on epilepsy, are involved in glioma progression, and their upregulated expression in peritumoral tissues is associated with epilepsy in glioma patients (Huang et al., 2015). The gene discussed is ADA; the disease is epilepsy.